About Epselon
We aren’t here to be just another vendor. We came to the table to change how healthcare companies do business by providing an unparalleled level of service and partnership.
Our story.
The name Epselon is a reference to the Greek letter "Epsilon'', the fifth letter in the greek alphabet and is symbolic for this venture as it is the fifth time Michael Mulhern has partnered with GTCR, a Chicago-based leading private equity firm. Epselon is working to build a market-leading healthcare business by strategically acquiring companies and assets that solve some of healthcare’s most intricate challenges.
Our team.
Everyone in the Epselon Global ecosystem shares the same vision—to radically transform our culture of care with innovative, purpose-driven solutions.
Michael Mulhern
Executive Chairman
"To be successful businesses need to be in a constant state of transformation."
Mr. Mulhern is a seasoned business executive with a 35+ year track record of success across a variety of industry verticals: medical technology, pharma services, distribution and consumer products. Mr. Mulhern is highly experienced in leading private equity-backed companies. Over the last 20 years Mr. Mulhern has served as Chairman and CEO of four separate GTCR portfolio companies: AMRI Global, Sotera Health, Fairmount Food Group and American Sanitary. He previously held leadership roles at Baxter International and Alliant Foodservice. Epselon Global represents the fifth time GTCR has partnered with Mr. Mulhern. Additionally, he serves as an outside director of GTCR portfolio companies Albany Molecular Research and Regatta Medical. Michael received a BA in Economics from Penn State University.
Read More
Read Less
Ben Bernstein
Sr VP of Business Development
"Healthcare is the ultimate sector for doing well while doing good."
Ben Bernstein serves as Senior Vice President of Business Development for Epselon Global. Ben has over 20 years of experience in strategic business development and M&A in the life sciences sector. Most recently, Ben was Head of Strategy for Sartorius, a global leader in bioprocessing and laboratory products. Ben was responsible for developing and implementing the long-term strategy for the Bioprocess Solutions division including the evaluation and execution of M&A opportunities. Previously, Ben was responsible for sourcing, evaluating and executing on inorganic growth opportunities at Cantel Medical and Catalent. Before that, Ben spent 10 years in life sciences venture capital and investment firms. Ben received his BS in Applied Economics and Management from Cornell University.
Read More
Read Less
Contact us.
Have questions about who we are, what we do, or how to partner with us?